Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
Key Highlights
- ➤Q3 2026 financial results scheduled for November 5, 2026
- ➤Conference call set for November 5 at 5:00 p.m. Eastern Time
- ➤Starling Oncology serves approximately 2.2 million patients across five states
- ➤Company operates over 100 clinics and network locations with 400-plus clinicians
CERRITOS, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (“STLN”) (NASDAQ: STLN) a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2026 financial results on Thursday, November 5, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-800-347-6865 or, for international callers, 1-203-518-9757, and referencing Conference ID: STARLING. A replay will be available approximately three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the replay is 11162885. The replay will be available until 11:59 p.m. (Eastern Time) on Thursday, November 19, 2026.
Get started
Create a free account to read the full story.